Multivalent mRNA vaccine platform with compatible antigens conferred broad-spectrum protection against orthoebolaviruses' exposure.

Zhang J, Zhang X, Yao Y, Zhou J, Chen D, Shen Y, Gong Q, Li Z, Zhou Z, Li E, Li F, Cheng Z, Liu Y, Wang W, Liu H, Chen M, Zhang H, Wang C, Wang Y, Chiu S

Open source

DOI
10.1073/pnas.2517814123
Published
2026 May 26
Container
Proceedings of the National Academy of Sciences of the United States of America
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1073/pnas.2517814123,
  title = {Multivalent mRNA vaccine platform with compatible antigens conferred broad-spectrum protection against orthoebolaviruses' exposure.},
  author = {Zhang J and Zhang X and Yao Y and Zhou J and Chen D and Shen Y and Gong Q and Li Z and Zhou Z and Li E and Li F and Cheng Z and Liu Y and Wang W and Liu H and Chen M and Zhang H and Wang C and Wang Y and Chiu S},
  year = {2026},
  journal = {Proceedings of the National Academy of Sciences of the United States of America},
  doi = {10.1073/pnas.2517814123},
  url = {https://doi.org/10.1073/pnas.2517814123}
}

RIS

TY  - JOUR
TI  - Multivalent mRNA vaccine platform with compatible antigens conferred broad-spectrum protection against orthoebolaviruses' exposure.
AU  - Zhang J
AU  - Zhang X
AU  - Yao Y
AU  - Zhou J
AU  - Chen D
AU  - Shen Y
AU  - Gong Q
AU  - Li Z
AU  - Zhou Z
AU  - Li E
AU  - Li F
AU  - Cheng Z
AU  - Liu Y
AU  - Wang W
AU  - Liu H
AU  - Chen M
AU  - Zhang H
AU  - Wang C
AU  - Wang Y
AU  - Chiu S
PY  - 2026
JO  - Proceedings of the National Academy of Sciences of the United States of America
DO  - 10.1073/pnas.2517814123
UR  - https://doi.org/10.1073/pnas.2517814123
ER  - 

APA

J, Z., X, Z., Y, Y., J, Z., D, C., Y, S., Q, G., Z, L., Z, Z., E, L., F, L., Z, C., Y, L., W, W., H, L., M, C., H, Z., C, W., Y, W., & S, C. (2026). Multivalent mRNA vaccine platform with compatible antigens conferred broad-spectrum protection against orthoebolaviruses' exposure.. Proceedings of the National Academy of Sciences of the United States of America. https://doi.org/10.1073/pnas.2517814123

Source records